An epigenetic approach to the treatment of advanced MDS; the experience with the DNA demethylating agent 5-aza-2'-deoxycytidine (decitabine) in 177 patients (Q46740971)

From Wikidata

Jump to navigation Jump to search

scientific article

edit

Language	Label	Description	Also known as
English	An epigenetic approach to the treatment of advanced MDS; the experience with the DNA demethylating agent 5-aza-2'-deoxycytidine (decitabine) in 177 patients	scientific article

Statements

instance of

scholarly article

1 reference

stated in

Europe PubMed Central

PubMed publication ID

16211386

retrieved

24 December 2017

reference URL

http://europepmc.org/abstract/MED/16211386

meta-analysis

0 references

title

An epigenetic approach to the treatment of advanced MDS; the experience with the DNA demethylating agent 5-aza-2'-deoxycytidine (decitabine) in 177 patients (English)

1 reference

stated in

Europe PubMed Central

PubMed publication ID

16211386

retrieved

24 December 2017

reference URL

http://europepmc.org/abstract/MED/16211386

main subject

patient

0 references

author name string

P W Wijermans

series ordinal

1

1 reference

stated in

Europe PubMed Central

PubMed publication ID

16211386

retrieved

24 December 2017

reference URL

http://europepmc.org/abstract/MED/16211386

M Lübbert

series ordinal

2

1 reference

stated in

Europe PubMed Central

PubMed publication ID

16211386

retrieved

24 December 2017

reference URL

http://europepmc.org/abstract/MED/16211386

G Verhoef

series ordinal

3

1 reference

stated in

Europe PubMed Central

PubMed publication ID

16211386

retrieved

24 December 2017

reference URL

http://europepmc.org/abstract/MED/16211386

V Klimek

series ordinal

4

1 reference

stated in

Europe PubMed Central

PubMed publication ID

16211386

retrieved

24 December 2017

reference URL

http://europepmc.org/abstract/MED/16211386

A Bosly

series ordinal

5

1 reference

stated in

Europe PubMed Central

PubMed publication ID

16211386

retrieved

24 December 2017

reference URL

http://europepmc.org/abstract/MED/16211386

publication date

1 December 2005

1 reference

stated in

Europe PubMed Central

PubMed publication ID

16211386

retrieved

24 December 2017

reference URL

http://europepmc.org/abstract/MED/16211386

published in

Annals of Hematology

1 reference

stated in

Europe PubMed Central

PubMed publication ID

16211386

retrieved

24 December 2017

reference URL

http://europepmc.org/abstract/MED/16211386

volume

84 Suppl 1

1 reference

stated in

Europe PubMed Central

PubMed publication ID

16211386

retrieved

24 December 2017

reference URL

http://europepmc.org/abstract/MED/16211386

page(s)

9-17

1 reference

stated in

Europe PubMed Central

PubMed publication ID

16211386

retrieved

24 December 2017

reference URL

http://europepmc.org/abstract/MED/16211386

Identifiers

DOI

10.1007/S00277-005-0012-1

1 reference

stated in

Europe PubMed Central

PubMed publication ID

16211386

retrieved

24 December 2017

reference URL

http://europepmc.org/abstract/MED/16211386

Fatcat ID

release_5ljmcdilbrbelp2h3fcyrj2hie

1 reference

stated in

Fatcat

reference URL

https://api.fatcat.wiki/v0/release/5ljmcdilbrbelp2h3fcyrj2hie

retrieved

24 November 2022

based on heuristic

mapped directly with Wikidata item

PubMed publication ID

16211386

1 reference

stated in

Europe PubMed Central

PubMed publication ID

16211386

retrieved

24 December 2017

reference URL

http://europepmc.org/abstract/MED/16211386

 

Sitelinks

Wikipedia(0 entries)

edit

Wikibooks(0 entries)

edit

Wikinews(0 entries)

edit

Wikiquote(0 entries)

edit

Wikisource(0 entries)

edit

Wikiversity(0 entries)

edit

Wikivoyage(0 entries)

edit

Wiktionary(0 entries)

edit

Multilingual sites(0 entries)

edit

Retrieved from "https://www.wikidata.org/w/index.php?title=Q46740971&oldid=2129515865"